DOI: 10.3724/SP.J.1263.2012.00005

Journal of Geriatric Cardiology 2012/9:1 PP.5-10

Prevalence of cardiovascular disease in subjects hospitalized due to chronic obstructive pulmonary disease in Beijing from 2000 to 2010

Objectives To investigate the overall prevalence of cardiovascular disease (CVD) in subjects hospitalized for chronic obstructive pulmonary disease (COPD), and explore the prevalence of the major CVD complications and trends in patients with COPD over a 10-year period. Methods Medical records in the PLA General Hospital, Beijing Union Medical College Hospital, and Beijing Hospital from 2000/01/01 to 2010/03/03 were retrospectively reviewed. A total of 4960 patients with COPD were reviewed in the study (3570 males, mean age, 72.2 ± 10.5 years; 1390 females, mean age, 72.0 ± 10.4 years). Results The prevalence of CVD in COPD patients was 51.7%. The three most prevalent CVDs were ischemic heart disease (28.9%), heart failure (19.6%), and arrhythmia (12.6%). During the 10-year study period, the prevalence of various CVDs in COPD patients showed a gradual increasing trend with increasing age. There was higher morbidity due to ischemic heart disease (P < 0.01) in male COPD patients than in the female counterparts. However, heart failure (P < 0.01) and hypertension (P < 0.01) occurred less frequently in male COPD patients than in female COPD patients. Furthermore, the prevalence of ischemic heart disease decreased year by year. In addition to heart failure, various types of CVD complications in COPD patients tended to occur in younger subjects. The prevalence of all major types of CVD in women tended to increase year by year. Conclusions The prevalence of CVD in patients hospitalized for COPD in Beijing was high. Age, sex and CVD trends, as well as life style changes, should be considered when prevention and control strategies are formulated.

Key words:Prevalence,Cross-sectional investigation,Chronic obstructive pulmonary disease,Cardiovascular disease

ReleaseDate:2014-07-21 16:08:56

1 Cazzola M, Bettoncelli G, Sessa E, et al. Prevalent ratio of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010; 80: 112-119.

2 Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis 2008; 51: 213-228.

3 Hanrahan JP, Grogan DR, Baumgartner RA, et al. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore) 2008; 87: 319-328.

4 Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646.

5 Malerba M, Romanelli G. Early cardiovascular involvement in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2009, 71: 59-65.

6 Agusti A. Thomas N. Chronic obstructive pulmonary disease: a systemic disease. Proc Am Thorac Soc 2006; 3: 478-481.

7 Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology 2003; 8: 17-21.

8 Tuder RM. Aging and cigarette smoke: fueling the fire. Am J Respir Crit Care Med 2006; 174: 490-491.

9 Cazzola M, Donner CF, Hanania NA. One hundred years of chronic obstructive pulmonary disease (COPD). Respir Med 2007; 101: 1049-1065.

10 Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest 2007; 131: 1557-1566.

11 Almagro P, López García F, Cabrera F, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010; 104: 253-259.

12 de Torres JP, Cote CG, López MV, et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009; 33: 528-535.

13 Basili S, Ferroni P, Vieri M, et al. Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease. Atherosclerosis 1999; 147: 249-252.

14 de Torres JP, Casanova C, Hernández C, et al. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128: 2012-2016.

15 Schroeder SA. Shattuck Lecture. We can do better improving the health of the American people. N Engl J Med 2007; 357: 1221-1228.

16 Schroeder SA. Tobacco control in the wake of the 1998 master settlement agreement. N Engl J Med 2004; 350: 293-301.

17 Boggia B, Farinaro E, Grieco L, et al. Burden of smoking and occupational exposure on etiology of chronic obstructive pulmonary disease in workers of Southern Italy. J Occup Environ Med 2008; 50: 366-370.

18 Mills NL, Donaldson K, Hadoke PW, et al. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med 2009; 6: 36-44.

19 Sidney S, Sorel M, Quesenberry CP Jr, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-2075.

20 Macnee W, Maclay J, McAllister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5824-5833.

21 Curkendall SM, DeLuise C, Jones JK, et al. cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.

22 Brassard P, Ferland A, Marquis K, et al. Impact of diabetes, chronic heart failure, congenital heart disease and chronic obstructive pulmonary disease on acute and chronic exercise responses. Can J Cardiol 2007; 23 (Suppl ): S89-S96.

23 Rusinaru D, Saaidi I, Godard S, et al. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol 2008; 101: 353-358.

24 Sin DD, Paul SF. Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008; 14: 115-121.

25 Robert A, Stockley. Progression of chronic obstructive Pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Current Medical Research and Opinion 2009; 25: 1235-1245.